Skip to main content
. 2023 Sep 15;220(11):e20230926. doi: 10.1084/jem.20230926

Table 1.

Patient characteristics

Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Age, year 4 6 9 14 15
Specimen used for genotyping Muscle Muscle Muscle Muscle Muscle
DNA changes c.1633G>A c.3140A>G c.1624G>A c.1624G>A c.1633G>A
VAF (%)a 15 25 12 21 14
Amino acid change p.Glu545Lys p.His1047Arg p.Glu542Lys p.Glu542Lys p.Glu545Lys
COSMICb genomic mutation ID COSV55873239 COSV55873195 COSV55873227 COSV55873227 COSV55873239
Treatments prior to alpelisib - - Botulinum toxin injections - Botulinum toxin injections
a

Corresponds to the percentage of alternate or mutant reads to total reads detected by next-generation sequencing.

b

Catalogue of Somatic Mutations in Cancer.